Sign in

Vivek Jain [January 31

Chairman of the Board and Chief Executive Officer (CEO) at ICU MEDICAL INC/DE
Board
Since February 2014
Age
52 years
Tenure
Joined ICU Medical in February 2014 and has served as Chairman of the Board and Chief Executive Officer since that time.

Also at ICU MEDICAL INC/DE

BB[3
Brian Bonnell [January 31
Chief Financial Officer (CFO) and Treasurer
CV[3
Christian Voigtlander [January 31
Chief Operating Officer (COO)
DW[3
Daniel Woolson [January 31
President

About

Vivek Jain is currently 52 years old as of January 31, 2025. He embarked on a distinguished career in healthcare and finance, holding leadership roles with J.P. Morgan, Philips Medical Systems, Cardinal Health, and CareFusion before assuming his current role.

In February 2014, he joined ICU Medical, where he has since served as Chairman of the Board and Chief Executive Officer. His comprehensive background in investment banking and corporate strategy has been pivotal in his leadership at the company.

Beyond his executive responsibilities at ICU Medical, he has contributed his expertise as a board member for Envista Holdings Corporation since 2020, further reflecting his commitment and impact within the healthcare industry.

$ICUI Performance Under Vivek Jain [January 31

Past Roles

OrganizationRoleDate RangeDetails
CareFusion Corporation President of Procedural Solutions 2011 to February 2014 Held until joining ICUI
CareFusion Corporation President, Medical Technologies and Services 2009 to 2011 N/A
Cardinal Health Executive Vice-President-Strategy and Corporate Development 2007 to 2009 N/A
Philips Medical Systems (Koninklijke Philips Electronics N.V.) Senior Vice President, Business Development and M&A 2006 to August 2007 N/A
J.P. Morgan Securities, Inc. Co-Head of Global Healthcare Investment Banking 2002 to 2006 Last position held
J.P. Morgan Securities, Inc. Investment Banker 1994 to 2006 N/A

External Roles

OrganizationRoleDate RangeDetails
Envista Holdings Corporation Board of Directors Since 2020 Current active role outside of ICUI

Fixed Compensation

Data from  FY 2023
Component NameAmountPayment ScheduleAdditional Details
Base Salary$775,000 AnnualBase salary for 2023, unchanged from 2022
BonusNone N/ANo discretionary cash bonus for 2023
All Other Compensation$16,500 AnnualIncludes 401(k) match
Time-Based RSUs Value$2,777,142 Vesting over 3 years14,615 RSUs granted on May 17, 2023; vests in equal annual increments

Performance Compensation

Data from  FY 2023

Annual Cash Incentives

MetricDetails
Bonus Basis$775,000 (Base Salary)
Performance MetricsAdjusted EBITDA & Free Cash Flow (weighted 50% each)
Adjusted EBITDA GoalsThreshold: $375M, Target: $400M, Stretch: $425M
Free Cash Flow GoalsThreshold: $50M, Target: $100M, Stretch: $150M
Payout PercentagesThreshold: 50%, Target: 100%, Stretch: 150%
Actual ResultsAdjusted EBITDA: $376.1M, FCF: $83.8M
Actual Payout60% of Target Bonus, $465,000
PaymentAnnual payout based on FY 2023 performance

Performance-Based RSUs

MetricDetails
Performance Metrics3-year adjusted revenue CAGR & 3-year Adjusted EBITDA CAGR (weighted 50% each)
Share TargetsThreshold: 3,654 shares, Target: 14,616 shares, Maximum: 36,540 shares
Grant DateMay 17, 2023
Grant Date Fair Value$2,777,332
Grant Date Stock Price$190.02
Vesting ScheduleVests in equal annual increments over 3 years; performance RSUs vest at end of 2025
Evaluation PeriodJanuary 1, 2023 to December 31, 2025
ConditionsMust achieve minimum performance thresholds; forfeited if goals not met